tiprankstipranks
Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
US Market

Compare Actuate Therapeutics, Inc. (ACTU) vs. Competitors

38 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Actuate Therapeutics, Inc.
$2.31
$48.33M
-80.89%
3 Buy
0 Hold
0 Sell
Strong Buy
Agenus
$4.79
$141.58M
2.06
9.37%
1 Buy
0 Hold
0 Sell
Moderate Buy
Black Diamond Therapeutics
$3.06
$127.21M
-2.94
-1.33%
5 Buy
0 Hold
0 Sell
Strong Buy
Nkarta
$3.47
$232.52M
79.56%
6 Buy
0 Hold
0 Sell
Strong Buy
C4 Therapeutics
$2.92
$483.18M
231.06%
4 Buy
0 Hold
0 Sell
Strong Buy
Kyverna Therapeutics, Inc.
$9.93
$517.98M
223.95%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ACTU
Actuate Therapeutics, Inc.
2.02
-8.57
-80.93%
AGEN
Agenus
3.50
-0.63
-15.25%
BDTX
Black Diamond Therapeutics
2.22
-0.15
-6.33%
NKTX
Nkarta
3.25
1.52
87.86%
CCCC
C4 Therapeutics
4.37
3.04
228.57%
KYTX
Kyverna Therapeutics, Inc.
8.52
5.87
221.51%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts